Patent Marking Notice
This patent information is provided to satisfy the virtual patent marking provisions of various jurisdictions, including the relevant provisions of the America Invents Act, and provides the necessary notice under 35 U.S.C. § 287(a). In accordance with Section 287(a) of Title 35 of the United States Code and corresponding international patent marking requirements, the following list identifies Unigen’s rights in patents worldwide associated with the relevant products.
The products listed below, either alone or in combination with other product(s), are protected by one or more of the identified patents in the United States and other jurisdictions globally. Additional patents may be issued and/or pending in the U.S. or elsewhere. The following list of Unigen products may not be all inclusive, and other Unigen products not listed here may be protected by one or more patents.
The contents of this portfolio are subject to change due to issuance, licensing or expiration of patent rights, product changes or launches and other circumstances. The absence of a product or patent number from this list does not constitute a waiver of Unigen’s patent, trademark, or other intellectual property rights concerning that product or patent.
Note: Patent numbers marked as “Pending” indicate patent applications that have been filed but not yet granted. Country codes follow ISO standard two-letter abbreviations (e.g., US = United States, EP = European Patent Office, CN = China, JP = Japan, KR = South Korea).
| Product | Patent Numbers |
|---|---|
| AmLexin® |
US 11,123,393
US 9,717,770
US 10,583,161
US 11,554,153
US 12,042,523
CA 2,951,433
CA 3,057,129
IN 394,109
IN 336,433
JP 6,657,296
KR 10-1952416
KR 10-2223071
KR 10-2396831
KR 10-1954325
KR 10-2078357
KR 10-2393123
TW I718,432
Additional Patents Pending: US, CN, EP, IN, PH
|
| Attenutin™ |
AU 2021315608
Additional Patents Pending: US, AU, CA, CN, EP, IN, JP, NZ
|
| Bakutrol®, Bakutrol® A, Lumicyn™, and Lumicyn™ Pure |
US 9,713,596
US 10,905,654
US 10,434,073
US 11,013,699
US 11,253,486
US 11,918,547
AU 2012212153
CA 2,826,262
CN 101,217,968
CN 103,458,882
CN ZL201510390680.7
HK HK1120743
HK 1215792
JP 5,443,754
KR 1,431,060
KR 10-1802415
KR 2,156,731
KR 10-1954118
KR 10-2333655
KR 10-2525516
KR 2,642,352
MX 350,719
Additional Patents Pending: US, BR, CA
|
| FeraLuxe™ |
US 7,678,772
|
| Lasoperin™ |
MX 281,561
|
| Loesyn™ |
US 8,852,657
CA 2,675,027
CN ZL200880007809.X
EP 2117532
HK HK1140429
IT 2117532
KR 1,598,092
MX 316,273
TW I454,261
|
| Maizinol® |
Patents Pending: US, AU, BR, CA, CN, EP, HK, IN, JP, KR, NZ, TW
|
| Oravestin™ |
US 8,945,518
|
| Sebatin™ |
US 11,331,359
US 11,806,379
CA 2,991,773
IN 511,923
JP 7,202,323
JP 7,203,780
KR 10-2470579
KR 10-2470576
Additional Patents Pending: CN
|
| Symetrian™ |
AU 2021310189
TW I801,925
Additional Patents Pending: US, AU, CA, CN, EP, KR, NZ, SG
|
| Univestin® |
US 7,674,830
US 9,655,940
|

